Prevention of thalidomide-and lenalidomide-associated thrombosis in myeloma
The incidence of venous thromboembolism (VTE) is more than 1‰ annually in the general
population and increases further in cancer patients. The risk of VTE is higher in multiple …
population and increases further in cancer patients. The risk of VTE is higher in multiple …
[HTML][HTML] The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the …
NWCJ van de Donk, A Palumbo, HE Johnsen… - …, 2014 - ncbi.nlm.nih.gov
Monoclonal gammopathy of undetermined significance is one of the most common pre-
malignant disorders. IgG and IgA monoclonal gammopathy of undetermined significance are …
malignant disorders. IgG and IgA monoclonal gammopathy of undetermined significance are …
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study
SY Kristinsson, RM Pfeiffer, M Björkholm… - Blood, The Journal …, 2010 - ashpublications.org
Patients with multiple myeloma (MM) have an increased risk of venous thrombosis.
Interestingly, excess risk of venous thromboembolism has been observed among patients …
Interestingly, excess risk of venous thromboembolism has been observed among patients …
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
SY Kristinsson, TR Fears, G Gridley… - Blood, The Journal …, 2008 - ashpublications.org
Patients with multiple myeloma (MM) have an increased risk of deep venous thrombosis
(DVT), particularly when treated with immunomodulatory drugs. Recently, 2 small hospital …
(DVT), particularly when treated with immunomodulatory drugs. Recently, 2 small hospital …
[PDF][PDF] UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of …
J Bird, J Behrens, J Westin… - British journal of …, 2009 - academy.myeloma.org.uk
1Avon Haematology Unit, Bristol Haematology and Oncology Centre, Bristol, 2Department
of Haematology, St Helier Hospital, Carshalton, Surrey, UK, 3Department of Haematology …
of Haematology, St Helier Hospital, Carshalton, Surrey, UK, 3Department of Haematology …
Monoclonal gammopathy of undetermined significance: a consensus statement
JR Berenson, KC Anderson, RA Audell… - British journal of …, 2010 - Wiley Online Library
Summary On February 25, 2009, a panel of international experts on plasma cell dyscrasia
and skeletal disease met to discuss monoclonal gammopathy of undetermined significance …
and skeletal disease met to discuss monoclonal gammopathy of undetermined significance …
Monoclonal gammopathy of undetermined significance and smouldering multiple myeloma: emphasis on risk factors for progression
RA Kyle, SV Rajkumar - British journal of haematology, 2007 - Wiley Online Library
Monoclonal gammopathy of undetermined significance (MGUS) is characterized by a serum
monoclonal protein< 30 g/l,< 10% plasma cells in the bone marrow, and absence of end …
monoclonal protein< 30 g/l,< 10% plasma cells in the bone marrow, and absence of end …
[HTML][HTML] Lenalidomide and pegylated liposomal doxorubicin-based chemotherapy for relapsed or refractory multiple myeloma: safety and efficacy
R Baz, E Walker, MA Karam, TK Choueiri, RA Jawde… - Annals of oncology, 2006 - Elsevier
Background Lenalidomide is active and well tolerated in relapsed and refractory multiple
myeloma. We conducted a phase I/II trial of the combination of lenalidomide and …
myeloma. We conducted a phase I/II trial of the combination of lenalidomide and …
Cancer-associated thrombosis
HE Fuentes, AJ Tafur, JA Caprini - Disease-a-Month, 2016 - Elsevier
Venous thromboembolism (VTE) is one of the three most common cardiovascular diseases
in the United States. It is also a leading cause of death among patients with cancer. Cancer …
in the United States. It is also a leading cause of death among patients with cancer. Cancer …
Pathogenesis and management of bleeding and thrombosis in plasma cell dyscrasias
C Eby - British journal of haematology, 2009 - Wiley Online Library
Unexpectedly high rates of venous thromboembolic events (VTE) concurrent with the
introduction of highly effective immune modulating drugs thalidomide and lenolidomide for …
introduction of highly effective immune modulating drugs thalidomide and lenolidomide for …